Differential regulation of a placental SAM68 and sFLT1 gene pathway and the relevance to maternal vitamin D sufficiency.

What Was Tested

This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.

Who Took Part

The abstract describes 43 subjects taking part.

The age groups tagged for this paper are adults, women only.

QPCR analysis of NKX2-5, SAM68, sFLT1 and membrane bound VEGFR1/FLT1 mRNA expression was conducted in placentas from 43 subjects enrolled in a vitamin D3 pregnancy supplementation trial.

Pair-wise rank order correlations between patient-specific gene expression levels were calculated, and their relationship to maternal 25(OH)D status was assessed by a two-sample Wilcoxon test.

How the Study Was Run

The design is described as randomized.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Additionally, the researchers probed the mechanistic link between SAM68 and sFLT1 using siRNA depletion in a human trophoblast cell line model.

What Was Measured

PubMed files the paper under topics including Adaptor Proteins, Signal Transducing, Cells, Cultured, DNA, Complementary, DNA-Binding Proteins, Gene Expression, Placenta and Pre-Eclampsia.

The authors tagged it with the keywords NKX2-5, Preeclampsia, Pregnancy, SAM68 and sFLT1.

What This Means in Plain Language

The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 43 subjects.

The abstract goes on to report its results in about 6 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2020 (Pregnancy hypertension), a journal based in Netherlands.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.